Hasil Pencarian - Christopher D Lao
- Menampilkan 1 - 11 hasil dari 11
-
1
-
2
Metastatic Merkel cell carcinoma response to nivolumab oleh Leslie A. Fecher, Frances M. Walocko, Benjamin Y. Scheier, Paul W. Harms, Christopher D. Lao
Diterbitkan 2016-12-01
Artikel -
3
Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512. oleh Shailender Bhatia, James Moon, Kim A Margolin, Jeffrey S Weber, Christopher D Lao, Megan Othus, Ana M Aparicio, Antoni Ribas, Vernon K Sondak
Diterbitkan 2012-01-01
Artikel -
4
Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab oleh Vincent T. Ma, Vincent T. Ma, Alahendra A. Chamila Perera, Yilun Sun, Yilun Sun, Merna Sitto, Jessica J. Waninger, Jessica J. Waninger, Govind Warrier, Michael D. Green, Michael D. Green, Leslie A. Fecher, Christopher D. Lao
Diterbitkan 2022-07-01
Artikel -
5
A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma oleh Joseph I. Clark, Jatinder Singh, Marc S. Ernstoff, Christopher D. Lao, Lawrence E. Flaherty, Theodore F. Logan, Brendan Curti, Sanjiv S. Agarwala, Bret Taback, Lee Cranmer, Jose Lutzky, Theresa L. Luna, Sandra Aung, David H. Lawson
Diterbitkan 2018-07-01
Artikel -
6
Metastatic melanoma of the heart: Retrospective cohort study and systematic review of prevalence, clinical characteristics, and outcomes oleh Alexander M. Balinski, Alexi L. Vasbinder, Connor C. Kerndt, Tonimarie C. Catalan, Nathan P. Parry, Rafey A. Rehman, Pennelope Blakely, Raymond Y. Yeow, Monika J. Leja, Christopher D. Lao, Leslie A. Fecher, Salim S. Hayek
Diterbitkan 2023-02-01
Artikel -
7
Complete Response After Stereotactic Body Radiation Therapy With Concurrent Immunotherapy for Vaginal Melanoma oleh Caitlin A. Schonewolf, MD, MSCTS, Elizabeth M. Jaworski, MD, Steven G. Allen, MD, PhD, Karen McLean, MD, Christopher D. Lao, MD, Lynn M. Schuchter, MD, Janos Tanyi, MD, PhD, Neil K. Taunk, MD, MSCTS
Diterbitkan 2022-03-01
Artikel -
8
Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial oleh Michelle M. Kim, Hemant Parmar, Yue Cao, Priyanka Pramanik, Matthew Schipper, James Hayman, Larry Junck, Aaron Mammoser, Jason Heth, Corey A. Carter, Arnold Oronsky, Susan J. Knox, Scott Caroen, Bryan Oronsky, Jan Scicinski, Theodore S. Lawrence, Christopher D. Lao
Diterbitkan 2016-04-01
Artikel -
9
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study oleh Aleksandar Sekulic, Michael R. Migden, Nicole Basset-Seguin, Claus Garbe, Anja Gesierich, Christopher D. Lao, Chris Miller, Laurent Mortier, Dedee F. Murrell, Omid Hamid, Jorge F. Quevedo, Jeannie Hou, Edward McKenna, Natalie Dimier, Sarah Williams, Dirk Schadendorf, Axel Hauschild, for the ERIVANCE BCC Investigators
Diterbitkan 2017-05-01
Artikel -
10
Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study oleh Aleksandar Sekulic, Michael R. Migden, Nicole Basset-Seguin, Claus Garbe, Anja Gesierich, Christopher D. Lao, Chris Miller, Laurent Mortier, Dedee F. Murrell, Omid Hamid, Jorge F. Quevedo, Jeannie Hou, Edward McKenna, Natalie Dimier, Sarah Williams, Dirk Schadendorf, Axel Hauschild, for the ERIVANCE BCC Investigators
Diterbitkan 2019-04-01
Artikel -
11
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition oleh Elizabeth I. Buchbinder, Janice P. Dutcher, Gregory A. Daniels, Brendan D. Curti, Sapna P. Patel, Shernan G. Holtan, Gerald P. Miletello, Mayer N. Fishman, Rene Gonzalez, Joseph I. Clark, John M. Richart, Christopher D. Lao, Scott S. Tykodi, Ann W. Silk, David F. McDermott
Diterbitkan 2019-02-01
Artikel